These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31831161)

  • 41. Synthesis and antibacterial evaluation of novel cationic chalcone derivatives possessing broad spectrum antibacterial activity.
    Chu WC; Bai PY; Yang ZQ; Cui DY; Hua YG; Yang Y; Yang QQ; Zhang E; Qin S
    Eur J Med Chem; 2018 Jan; 143():905-921. PubMed ID: 29227931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive 2D-Quantitative Structure-Activity Relationship Study on Monobactam Analogues Against Gram-Negative Bacteria.
    Zhang D; Zhang X; Li Z; Tang S; Guo Z; Hu C; Zhang J; Song D; Li Y
    J Biomed Nanotechnol; 2020 Jun; 16(6):941-953. PubMed ID: 33187589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Moczygemba LR; Frei CR; Burgess DS
    Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
    Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
    Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monocyclic β-lactams loaded on hydroxyapatite: new biomaterials with enhanced antibacterial activity against resistant strains.
    Giacomini D; Torricelli P; Gentilomi GA; Boanini E; Gazzano M; Bonvicini F; Benetti E; Soldati R; Martelli G; Rubini K; Bigi A
    Sci Rep; 2017 Jun; 7(1):2712. PubMed ID: 28578416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.
    Decuyper L; Jukič M; Sosič I; Žula A; D'hooghe M; Gobec S
    Med Res Rev; 2018 Mar; 38(2):426-503. PubMed ID: 28815732
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Weiss WJ; Pulse ME; Nguyen P; Growcott EJ
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30642927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ceftazidime-Avibactam Antimicrobial Activity and Spectrum When Tested Against Gram-negative Organisms From Pediatric Patients: Results From the INFORM Surveillance Program (United States, 2011-2015).
    Sader HS; Huband MD; Duncan LR; Flamm RK
    Pediatr Infect Dis J; 2018 Jun; 37(6):549-554. PubMed ID: 29206750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria].
    Kuga A; Yano H; Okamoto R; Sato Y; Miyata A; Inoue M
    Jpn J Antibiot; 1999 Sep; 52(9):585-94. PubMed ID: 10746193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative in-vitro activity of tigemonam, a new monobactam.
    Rylander M; Gezelius L; Norrby SR
    J Antimicrob Chemother; 1988 Sep; 22(3):307-13. PubMed ID: 3182428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and in vitro antibacterial activity of new aminothiazole-oximepiperidone cephalosporins.
    Shen Z; Xu W; Yu J; Chen L; Zhang J; Sheng S; Dong X; Bian H
    Bioorg Med Chem Lett; 2021 May; 40():127928. PubMed ID: 33705899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monocyclic β-lactams as antibacterial agents: facing antioxidant activity of N-methylthio-azetidinones.
    Cervellati R; Galletti P; Greco E; Cocuzza CE; Musumeci R; Bardini L; Paolucci F; Pori M; Soldati R; Giacomini D
    Eur J Med Chem; 2013 Feb; 60():340-9. PubMed ID: 23314047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro antibacterial activity of BO-1165, a new monobactam antibiotic.
    Matsuda K; Nagashima M; Nakagawa S; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1986 Jun; 17(6):747-53. PubMed ID: 3525497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.
    Mitton-Fry MJ; Arcari JT; Brown MF; Casavant JM; Finegan SM; Flanagan ME; Gao H; George DM; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Irvine R; Lall MS; Megan Lemmon M; Li C; Lin J; McCurdy SP; Mueller JP; Mullins L; Niosi M; Noe MC; Pattavina D; Penzien J; Plummer MS; Risley H; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Winton J; Young JA
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5989-94. PubMed ID: 22892121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria.
    Pillar CM; Stoneburner A; Shinabarger DL; Krause KM; Nichols WW
    Lett Appl Microbiol; 2016 Aug; 63(2):96-102. PubMed ID: 27221329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-activity relations of 4-fluoromethyl monobactams.
    Matsuda K; Nakagawa S; Nakano F; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1987 Jun; 19(6):753-60. PubMed ID: 3497148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivo.
    van Ogtrop ML; Mattie H; Guiot HF; van Strijen E; Sekh BR; van Furth R
    Antimicrob Agents Chemother; 1991 Mar; 35(3):417-22. PubMed ID: 2039191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.